"Is this rotation the real thing?" asks Stephen "Sarge" Guilfoyle, a former New York Stock Exchange floor trader who co-manages TheStreet's Stocks Under $10 model portfolio and author of our daily Market Recon
During our monthly Trading Strategies roundtable, Guilfoyle said he was concerned that tax reform, the corporate AMT in particular, was going to cause high net worth investors to take some profits before year end.
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.